Founder, SVP Research & Development
Robby Booth serves as Glytec’s Senior Vice President of Research and Development, facilitating the company’s innovation programs, patent inventions and FDA clearances as well as multiple partnerships with vendors of complementary technologies. He has 20 years of experience in developing and commercializing disruptive solutions. Robby is one of Glytec’s founders and has been instrumental in advancing the company’s solutions for diabetes therapy management, including new models, algorithms and software-as-a-medical-device products for personalized digital therapeutics. He is an inventor of more than two dozen issued and allowed U.S. and international patents. Prior to joining Glytec, Robby was Vice President of Product Development at CoMed, where he was integral in building and managing design controls and overseeing activities to ensure compliance with medical device regulations.